AHA Coding Clinic® for HCPCS - 2008 Quarter 2; FOR your INFORMATION
Four new HCPCS codes for drugs and biologicals
drugs and biologicals The Centers for Medicare & Medicaid Services (CMS) has created four (4) new HCPCS codes that became effective April 1, 2008. We have listed the new HCPCS codes in the Table listed below: HCPCS - Long descriptor Q4096 Injection, Von Willebrand factor complex, human, ristocetin cofactor (not otherwise specified), per i.u. VWF: RCO Q4097 Injection, immune globulin (Privigen), intravenous, nonlyophilized (e.g., liquid), 500 mg Q4098 Injection, iron dextran, 50 mg C9241 Injection, doripenem, 10 mg Q4097 was previously reported under HCPCS codes J1751 , Injection, iron dextran 165, 50 mg , and J1752 , Injection, iron dextran...
Subscribe or sign in to view the full article.
Article Overview
This brief coding update is about CMS-issued HCPCS changes affecting drugs and biologicals. It is intended for hospital coders, billing staff, and compliance teams who track new code additions and reporting updates. The article provides a short list of newly effective HCPCS entries and a note about prior reporting under older HCPCS identifiers.
Why This Topic Matters
Timely awareness of HCPCS code updates helps organizations keep charge capture, claims processing, and compliance workflows aligned with current Medicare reporting requirements.
What You Will Learn
- Which new HCPCS drug and biologicals codes were introduced by CMS in April 2008.
- What type of coding update the article is announcing.
- How the update relates to hospital reporting under prior HCPCS identifiers.
- What timeframe the article associates with the HCPCS changes.
Who Should Read This
- Hospital coders
- Outpatient billing staff
- Revenue cycle professionals
- Compliance teams
- Medicare billing specialists
Codes Discussed
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com